Sunpla expected yearly to yeild 10 billion won of sales

As reported earlier SK Chemical and SK Pharmaceutical has developed an anti-cancer drug, a platinum complex, under the brand of Sunpla by about 8.1 billion won of investment during the past 10 years, which becomes the first drug having a new chemical entity in history of Korea. The followings are a brief back ground story of its development.

Dr. Kim Ki-dae, the chief of New Drug Development ...